USSTOCK.TODAY
Regular Market
Log in Sign up

Moderna shares fall 17% in a single trading day

The Motley Fool +1 ·

MRNA Moderna Inc
$202.63 -17.57%
View chart & analysis →
  1. 1Moderna shares experienced a 17% decline during a single trading day.
  2. 2Moderna and Merck reported a 42% reduction in the risk of death or recurrence in certain melanoma patients compared to Keytruda monotherapy.
  3. 3Moderna's stock price reacts very sensitively to the release of clinical trial data.

So what's the key point?

Moderna's stock price fell by 17% in just one day. This is because the stock price moves significantly whenever clinical trial results are announced.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Moderna shares plunge nearly 20% following cancer vaccine data leak Investor's Business Daily +18 · 14h agoUS Stocks Rise; Meta Platforms Ordered to Pay $25 billion in Damages Stocktwits +2 · yesterdayModerna transitions from COVID vaccines to cancer therapeutics The Motley Fool +1 · 2d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news